Microaneurysm density in residual oedema after anti-vascular endothelial growth factor therapy for diabetic macular oedema.
Yutaka YamadaYoshihiro TakamuraMasakazu MoriokaMakoto GozawaTakehiro MatsumuraMasaru InataniPublished in: Acta ophthalmologica (2020)
High MA density and extensive swelling may be characteristic of RO following treatment for DMO with intravitreal injection of either aflibercept or ranibizumab.